Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery after Focal Cerebral Ischemia

Stroke

Volumn 46, Issue 9, 2015, Pages 2628-2636

  Han, Lijuan ^a,b   Cai, Wei ^b,d   Mao, Leilei ^b   Liu, Jia ^c   Li, Peiying ^c   Leak, Rehana K ^e   Xu, Yun ^a   Hu, Xiaoming ^b,c,f   Chen, Jun ^b,c,f  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c FUDAN UNIVERSITY   (China)

^d THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e DUQUESNE UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

bromodeoxyuridine; inflammation; polarization; stroke; white matter

Indexed keywords

BROXURIDINE; GLUTAMINE; MICROTUBULE ASSOCIATED PROTEIN 2; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN SIZE; BRAIN TISSUE; BREGMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COGNITION; COLON POLYPOSIS; CONTROLLED STUDY; FLOW CYTOMETRY; GLIA CELL; LATERAL BRAIN VENTRICLE; MALE; MEMORY CONSOLIDATION; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REMYELINIZATION; SENSORIMOTOR FUNCTION; SPATIAL LEARNING; WHITE MATTER; WHITE MATTER INJURY; AGONISTS; ANIMAL; C57BL MOUSE; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; INFARCTION, MIDDLE CEREBRAL ARTERY; PATHOLOGY; REPERFUSION;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; OLIGODENDROGLIA; PPAR GAMMA; RECOVERY OF FUNCTION; REPERFUSION; THIAZOLIDINEDIONES; WHITE MATTER;

EID: 84940417011     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010091     Document Type: Article

References (36)

1. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641-1646. discussion 1647.
2. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab. 2003;23:263-274.
3. Ho PW, Reutens DC, Phan TG, Wright PM, Markus R, Indra I, et al. Is white matter involved in patients entered into typical trials of neuroprotection? Stroke. 2005;36:2742-2744. doi: 10.1161/01. STR.0000189748.52500.a7.
4. McIver SR, Muccigrosso M, Gonzales ER, Lee JM, Roberts MS, Sands MS, et al. Oligodendrocyte degeneration and recovery after focal cerebral ischemia. Neuroscience. 2010;169:1364-1375. doi: 10.1016/j. neuroscience.2010.04.070.
5. Zhang R, Chopp M, Zhang ZG. Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci. 2013;7:201. doi: 10.3389/fncel.2013.00201.
6. Goldman SA, Osorio J. So many progenitors, so little myelin. Nat Neurosci. 2014;17:483-485. doi: 10.1038/nn.3685.
7. Miyamoto N, Maki T, Pham LD, Hayakawa K, Seo JH, Mandeville ET, et al. Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke. 2013;44:3516-3521. doi: 10.1161/STROKEAHA.113.002813.
8. Zuhayra M, Zhao Y, von Forstner C, Henze E, Gohlke P, Culman J, et al. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat. Neuropathol Appl Neurobiol. 2011;37:738-752. doi: 10.1111/j.1365-2990.2011.01169.x.
9. Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, et al. Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats. Stroke. 2012;43:478-483. doi: 10.1161/STROKEAHA.111.618926.
10. Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, et al. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. J Neurochem. 2006;97:435-448. doi: 10.1111/j.1471-4159.2006.03758.x.
11. Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, Hamilton JA, et al. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke. 2013;44:3498-3508. doi: 10.1161/STROKEAHA.113.002470.
12. Wang CX, Ding X, Noor R, Pegg C, He C, Shuaib A. Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. J Cereb Blood Flow Metab. 2009;29:1683-1694. doi: 10.1038/jcbfm.2009.87.
13. Bernardo A, De Simone R, De Nuccio C, Visentin S, Minghetti L. The nuclear receptor peroxisome proliferator-activated receptor-γ promotes oligodendrocyte differentiation through mechanisms involving mitochondria and oscillatory Ca2+ waves. Biol Chem. 2013;394:1607-1614. doi: 10.1515/hsz-2013-0152.
14. Paintlia AS, Paintlia MK, Singh AK, Orak JK, Singh I. Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. Glia. 2010;58:1669-1685. doi: 10.1002/glia.21039.
15. Sim FJ, Lang JK, Ali TA, Roy NS, Vates GE, Pilcher WH, et al. Statin treatment of adult human glial progenitors induces PPAR gammamediated oligodendrocytic differentiation. Glia. 2008;56:954-962. doi: 10.1002/glia.20669.
16. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci. 2013;16:1211-1218. doi: 10.1038/nn.3469.
17. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods. 2002;117:207-214.
18. Pu H, Guo Y, Zhang W, Huang L, Wang G, Liou AK, et al. Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2013;33:1474-1484. doi: 10.1038/jcbfm.2013.108.
19. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43:3063-3070. doi: 10.1161/STROKEAHA.112.659656.
20. Sozmen EG, Kolekar A, Havton LA, Carmichael ST. A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates. J Neurosci Methods. 2009;180:261-272. doi: 10.1016/j. jneumeth.2009.03.017.
21. Maki T, Liang AC, Miyamoto N, Lo EH, Arai K. Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zonederived progenitor cells in white matter diseases. Front Cell Neurosci. 2013;7:275. doi: 10.3389/fncel.2013.00275.
22. Falcão AM, Marques F, Novais A, Sousa N, Palha JA, Sousa JC. The path from the choroid plexus to the subventricular zone: go with the flow! Front Cell Neurosci. 2012;6:34. doi: 10.3389/fncel.2012.00034.
23. Hu X, Leak RK, Shi Y, Suenaga J, Gao Y, Zheng P, et al. Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol. 2015;11:56-64. doi: 10.1038/nrneurol.2014.207.
24. Lee J, Reding M. Effects of thiazolidinediones on stroke recovery: a case-matched controlled study. Neurochem Res. 2007;32:635-638. doi: 10.1007/s11064-006-9138-3.
25. Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N, et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol. 2007;61:352-362. doi: 10.1002/ana.21097.
26. Gensert JM, Goldman JE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron. 1997;19:197-203.
27. Ortega F, Gascón S, Masserdotti G, Deshpande A, Simon C, Fischer J, et al. Oligodendrogliogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt signalling. Nat Cell Biol. 2013;15:602-613. doi: 10.1038/ncb2736.
28. Gonzalez-Perez O, Alvarez-Buylla A. Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev. 2011;67:147-156. doi: 10.1016/j.brainresrev.2011.01.001.
29. Chu M, Hu X, Lu S, Gan Y, Li P, Guo Y, et al. Focal cerebral ischemia activates neurovascular restorative dynamics in mouse brain. Front Biosci (Elite Ed). 2012;4:1926-1936.
30. Roth AD, Leisewitz AV, Jung JE, Cassina P, Barbeito L, Inestrosa NC, et al. PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes. J Neurosci Res. 2003;72:425-435. doi: 10.1002/jnr.10596.
31. Doonan F, Wallace DM, O'Driscoll C, Cotter TG. Rosiglitazone acts as a neuroprotectant in retinal cells via up-regulation of sestrin-1 and SOD-2. J Neurochem. 2009;109:631-643. doi: 10.1111/j.1471-4159.2009.05995.x.
32. Chen YC, Wu JS, Tsai HD, Huang CY, Chen JJ, Sun GY, et al. Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders. Mol Neurobiol. 2012;46:114-124. doi: 10.1007/s12035-012-8259-8.
33. Zhao X, Zhang Y, Strong R, Grotta JC, Aronowski J. 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab. 2006;26:811-820. doi: 10.1038/sj.jcbfm.9600233.
34. Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, et al. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab. 2007;27:1327-1338. doi: 10.1038/sj.jcbfm.9600438.
35. Wang G, Zhang J, Hu X, Zhang L, Mao L, Jiang X, et al. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab. 2013;33:1864-1874. doi: 10.1038/jcbfm.2013.146.
36. Mandrekar-Colucci S, Karlo JC, Landreth GE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci. 2012;32:10117-10128. doi: 10.1523/JNEUROSCI.5268-11.2012.